Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Baxter
Moodys
Mallinckrodt
Medtronic

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Exela Pharma Science Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA SCIENCE, and what generic and branded alternatives to EXELA PHARMA SCIENCE drugs are available?

EXELA PHARMA SCIENCE has two approved drugs.



Summary for Exela Pharma Science

Drugs and US Patents for Exela Pharma Science

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma Science NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride INJECTABLE;INJECTION 022276-001 Jul 24, 2008 RX No No   Start Trial   Start Trial
Exela Pharma Science NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE nicardipine hydrochloride INJECTABLE;INTRAVENOUS 022276-003 Apr 7, 2016 DISCN No No   Start Trial   Start Trial
Exela Pharma Science NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE nicardipine hydrochloride INJECTABLE;INTRAVENOUS 022276-002 Apr 7, 2016 DISCN No No   Start Trial   Start Trial
Exela Pharma Science CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 077233-001 Sep 21, 2006 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Mallinckrodt
Moodys
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.